ArticleScientific reports2026
Circulating pro-angiogenic cells are preserved despite myocardial angiogenic signal deficits in HFpEF model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Heart failure with preserved ejection fraction (HFpEF) has no cure, and microvascular dysfunction is a major contributing factor to its pathophysiology. Circulating endothelial progenitor cells (EPCs) and Angiogenic T (i.e., Tang) cells which support vascular repair are deficient in clinical HFpEF. The lack of data on circulating EPC and Tang cell counts in HFpEF models is an unmet critical gap in knowledge for potential therapeutic and biomarker development for HFpEF. In the clinically relevant HFpEF model (i.e., ZSF-1 obese rats), we hypothesized that circulating EPCs and Tang cell counts are significantly decreased compared to healthy control (WKY) rats. Thirty-eight-week-old male ZSF-1 obese and WKY rats were subjected to comprehensive phenotyping protocol, including echocardiography, exercise tolerance, aortic pressure measurement, and left ventricular diastolic function assessment. Blood was analyzed by flow cytometry for early (CD146⁺/CD34⁺/CD133⁺) and late (CD34⁺/CD146⁺) EPCs, as well as Tang cells (CD3⁺/CXCR4⁺/CD31⁺). Left ventricular expression of angiogenic genes (SDF1α, VEGFα) and pro-inflammatory IL-1β gene was quantified. ZSF-1 obese rats exhibited severe HFpEF phenotype with impaired diastolic function, elevated filling pressures, and significant exercise intolerance. Contrary to our expectations, circulating EPC and Tang cell counts in ZSF-1 obese rats are comparable to those of WKY rats whereas myocardial expression of SDF-1α and VEGF-α were markedly reduced and IL-1β gene increased. These findings suggest a novel dissociation between circulating and tissue angiogenic profiles in HFpEF. Preserved circulating pro-angiogenic cells despite myocardial angiogenic deficits suggests angiogenic dissociation as a potential mechanism underlying microvascular dysfunction in HFpEF. While ZSF-1 lean rats would have been the ideal control instead of WKY, targeting myocardial angiogenic pathways in HFpEF may represent a promising therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.